Drug therapy in pregnant and nursing women

Catherine S. Stika, Marilynn C. Frederiksen

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pregnant women and nursing women remain “therapeutic orphans” and pose definite challenges in regard to both drug selection and dosing. Although unnecessary medications should be avoided in both conditions, women with epilepsy, hypertension, diabetes, and other preexisting conditions need to continue therapy. Other pregnancy-specific conditions also may arise that need to be treated with medications. Optimal therapy of these patients requires cognizance of the profound physiological and metabolic changes that occur during pregnancy. These are discussed in this chapter as are the problems of teratogenesis and milk-based transfer of drugs to nursing infants. There is a continuing need for further pharmacologic studies in these patients and current recommendations and guidances for these are cited.

Original languageEnglish (US)
Title of host publicationAtkinson's Principles of Clinical Pharmacology
PublisherElsevier
Pages425-454
Number of pages30
ISBN (Electronic)9780128198698
ISBN (Print)9780128198841
DOIs
StatePublished - Jan 1 2021

Keywords

  • Drug metabolizing enzymes
  • Lactation
  • Pregnancy
  • Protein binding
  • Renal function
  • Teratogenesis

ASJC Scopus subject areas

  • General Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Drug therapy in pregnant and nursing women'. Together they form a unique fingerprint.

Cite this